Increased levels of 8-hydroxy-2′-deoxyguanosine (8-OHdG), peroxiredoxin-2 (PRDX2), and malondialdehyde and hydroxyalkenals (MDA+HAE), as markers of oxidative stress and lipid oxidation, have been identified in treatment naïve MS patients [3,6]. Here, PRDX2 is linked to myeloid sarcoma.